An impending showdown between Thoratec Corp.and HeartWare International Inc. in the left ventricular assist device market is not accelerating Thoratec executives’ pulse rates much, at least that was the message during the firm’s earnings call last week.
Thoratec currently has a virtual monopoly on the U.S. LVAD market with its HeartMate II rotary blood pump system. But...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?